Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag(Plex Pharmaceuticals (United States)), James Tsai(Toxikon (United States)), Jiazhong Zhang(Toxikon (United States)), Chao Zhang(Toxikon (United States)), Prabha N. Ibrahim(Universidad Estatal de Bolívar), K. B. Nolop(Universidad Estatal de Bolívar), Peter Hirth(Toxikon (United States))
Cited by 821
Abstract
Related Papers
No related papers found
Powered by citation graph analysis